DOI:
https://doi.org/10.18226/25253824.v8.n13.13Palabras clave:
Câncer de Estômago, Expressão Diferencial, Inteligência Artificial, Gene Expression Omnibus, The Cancer Genome Atlas.Resumen
Citas
de Araújo, N. D., de Farias, R. P., Pereira, P. B., de Figueirêdo, F. M., de Morais, A. M. B., Saldanha, L. C., & Gabriel, J. E. (2008). A era da bioinformática: seu potencial e suas implicações para as ciências da saúde. Estudos de biologia, 30(70/72): 143-8 https://doi.org/10.7213/reb.v30i70/72.22819
INSTITUTO Nacional de Câncer (INCA). O que é câncer? Disponível em <https://www.gov.br/inca/pt-br/assuntos/cancer/o-que-e-cancer>. Acesso em: 21 set. 2022.
Vogelstein, B., & Kinzler, K. W. (2015). The path to cancer—three strikes and you’re out. N Engl J Med, 373 (20), 1895-1898. https://www.nejm.org/doi/10.1056/NEJMp1508811
Ward, L. S. (2002). Entendendo o processo molecular da tumorigênese. Arquivos Brasileiros de Endocrinologia & Metabologia, 46, 351-360. https://doi.org/10.1590/S0004-27302002000400006
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 68 (6), 394-424. https://doi.org/10.3322/caac.21492
Yakirevich, E., & Resnick, M. B. (2013). Pathology of gastric cancer and its precursor lesions. Gastroenterology Clinics, 42 (2), 261-284. https://doi.org/10.1016/j.gtc.2013.01.004
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016). Gastric cancer. The Lancet, 388 (10060), 2654-2664. http://dx.doi.org/10.1016/S0140-6736(16)30354-3
Pasechnikov, V., Chukov, S., Fedorov, E., Kikuste, I., & Leja, M. (2014). Gastric cancer: prevention, screening and early diagnosis. World journal of gastroenterology: WJG, 20 (38), 13842. http://dx.doi.org/10.3748/wjg.v20.i38.13842
Lee, J. Y., Kim, H. I., Kim, Y. N., Hong, J. H., Alshomimi, S., An, J. Y., ... & Kim, C. B. (2016). Clinical significance of the prognostic nutritional index for predicting short-and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients. Medicine, 95 (18), e3539. https://doi.org/10.1097/md.0000000000003539
Matsuoka, T., & Yashiro, M. (2018). Biomarkers of gastric cancer: Current topics and future perspective. World journal of gastroenterology, 24 (26), 2818. https://doi.org/10.3748%2Fwjg.v24.i26.2818
Henry, N. L., & Hayes, D. F. (2012). Cancer biomarkers. Molecular oncology, 6 (2), 140-146. https://doi.org/10.1016/j.molonc.2012.01.010
Rossetto, M. V. (2019). Análise de expressão diferencial de genes: uma solução computacional para identificação de biomarcadores de tumores gástricos em humanos. Dissertação, Universidade de Caxias do Sul https://repositorio.ucs.br/11338/8780
Taya, M., & Hammes, S. R. (2018). Glycoprotein non-metastatic melanoma protein B (GPNMB) and cancer: a novel potential therapeutic target. Steroids, 133, 102-107. https://doi.org/10.1016/j.steroids.2017.10.013
Edgar, R., Domrachev, M., & Lash, A. E. (2002). Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic acids research, 30 (1), 207-210. https://doi.org/10.1093/nar/30.1.207
Cheng, L., Yang, S., Yang, Y., Zhang, W., Xiao, H., Gao, H., ... & Zhang, Q. (2012). Global gene expression and functional network analysis of gastric cancer identify extended pathway maps and GPRC5A as a potential biomarker. Cancer letters, 326(1), 105-113. https://doi.org/10.1016/j.canlet.2012.07.031
Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202-209, 2014.
Demšar, J., Curk, T., Erjavec, A., Gorup, Č., Hočevar, T., Milutinovič, M., ... & Zupan, B. (2013). Orange: data mining toolbox in Python. the Journal of machine Learning research, 14 (1), 2349-2353. https://www.jmlr.org/papers/volume14/demsar13a/demsar13a.pdf
Lazaratos, A. M., Annis, M. G., & Siegel, P. M. (2022). GPNMB: a potent inducer of immunosuppression in cancer. Oncogene, 41 (41), 4573-4590. https://doi.org/10.1038/s41388-022-02443-2
Li, H., Xiao, Y., Wu, C. C., Yang, L. L., Cao, L. Y., Chen, D. R., ... & Sun, Z. J. (2019). High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma. Histology and Histopathology, 34(7). https://doi.org/10.14670/hh-18-084
Ren, F., Zhao, Q., Liu, B., Sun, X., Tang, Y., Huang, H., ... & Mi, Y. (2020). Transcriptome analysis reveals GPNMB as a potential therapeutic target for gastric cancer. Journal of Cellular Physiology, 235(3), 2738-2752. https://doi.org/10.1002/jcp.29177
Huang, Y. H., Chu, P. Y., Chen, J. L., Huang, C. T., Huang, C. C., Tsai, Y. F., ... & Liu, C. Y. (2021). Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer. Scientific reports, 11 (1), 12171. https://doi.org/10.1038/s41598-021-91588-3
Maric, G., Rose, A. A., Annis, M. G., & Siegel, P. M. (2013). Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer. OncoTargets and therapy, 9 (6) 839-852. https://doi.org/10.2147/OTT.S44906
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Bianca de Andrade Lopes, Fernanda Pessi de Abreu, Pedro Lenz Casa, Marcos Vinícius Rossetto, Scheila de Avila e Silva
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Los autores conservan los derechos de autor y otorgan a la revista el derecho de primera publicación, con el trabajo licenciado simultáneamente bajo la Licencia de Creative Commons Atribución 4.0 Internacional (CC BY 4.0) que permite compartir el trabajo con reconocimiento de autoría del trabajo y publicación inicial en esta revista.